O’ZBEKISTONDA AYOLLAR ORASIDA HPV VIRUSINING TURLI YOSH GURUHLARIDA UCHRASH DARAJASI VA KLINIK XUSUSIYATLARI
Keywords:
HPV infection, DNA, chronic, vaccine.Abstract
Human Papillomavirus (HPV) is one of the most widespread viral infections globally, with a particularly high prevalence among the reproductive-age population. Approximately 99% of cervical cancer cases are linked to HPV infection [8]. In 2012, an estimated 528,000 new cases were reported worldwide. While most HPV infections resolve spontaneously, persistent infection with oncogenic or high-risk types can lead to cancers of the oropharyngeal and anogenital regions [5]. Global statistics indicate that roughly 11–12% of women aged 15–49 may be infected with HPV [2]. Furthermore, some studies suggest that the prevalence among sexually active young women can reach 20–30% [4]. These figures highlight the widespread nature of HPV and its status as a significant epidemiological challenge.
References
Bosch F.X. et al. The causal relation between human papillomavirus and cervical cancer, Journal of Clinical Pathology, 2002.
Bruni L. et al. Global estimates of human papillomavirus infection, Vaccine, 2010.
Centers for Disease Control and Prevention (CDC). HPV vaccination and screening guidelines, 2022.
De Sanjosé S. et al. Human papillomavirus infection prevalence worldwide, Lancet Infectious Diseases, 2007.
Mayrand M.-H. et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer, New England Journal of Medicine, 2007;357:1579–1588.
Schiffman M. et al. Human papillomavirus and cervical cancer, The Lancet, 2007.
Walboomers J.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer, Journal of Pathology, 1999.
World Health Organization. Human papillomavirus (HPV). Fact sheet [Internet]. Geneva: WHO; 2017 Apr 5 [cited 2026 Mar 6].
